
and Responsibilities
The Ocańas Lab is seeking a part-time Laboratory Technician to assist with tissue sectioning and related laboratory tasks. This position is ideal for an undergraduate student interested in biomedical research, medicine, or graduate/professional school who is looking to gain hands-on laboratory experience.
Responsibilities will include:
Minimum Qualifications
Preferred Qualifications
Work Hours
Flexible part-time hours, with scheduling available during the regular workweek, Monday through Friday, sometime between 8:30 a.m. and 5:00 p.m The position requires availability for at least 20 hours per week
OMRF Overview
Founded in 1946, the Oklahoma Medical Research Foundation (OMRF) is among the nation’s oldest, most respected independent, nonprofit biomedical research institutes. OMRF is dedicated to understanding and developing more effective treatments for human diseases, focusing on critical research areas such as Alzheimer’s disease, cancer, lupus, multiple sclerosis, and cardiovascular disease. OMRF follows an innovative cross-disciplinary approach to medical research and ranks among the nation’s leaders in patents per scientist.
Located in Oklahoma City, a city that offers a dynamic and flourishing downtown area, with low cost of living, short commute times and a diversified economy, OMRF has been voted one of the Top Workplaces since the inception of the award. This achievement has been accomplished thanks to OMRF individuals who share a unified understanding that our excellence can only be fully realized with a collective commitment to our mission, “. . . so that more may live longer, healthier lives.” Successful candidates will demonstrate commitment to this mission.
OMRF is an Equal Opportunity Employer.

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging.
Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF’s critical research is helping people live longer, healthier lives, one discovery at a time.
Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.